Tine Ginnerup Andreasen,Trine Strandgaard,Line Raaby et al.
Tine Ginnerup Andreasen et al.
Background: The recommended treatment for high-risk non-muscle invasive bladder cancer (NMIBC) is intravesical instillations of Bacillus Calmette-Guérin (BCG). Despite completing BCG therapy, up to 40% of patients experi...
Emerging bladder-sparing treatments for high risk non-muscle invasive bladder cancer [0.03%]
高危非肌层浸润性膀胱癌的新兴保膀胱疗法
Clarissa M Gurbani,Yew-Lam Chong,Zhen Wei Choo et al.
Clarissa M Gurbani et al.
Bladder cancer (BC) is a significant global health concern, with non-muscle invasive bladder cancer (NMIBC) comprising 75% of cases at diagnosis. High-risk NMIBC (HR-NMIBC) poses a significant therapeutic challenge due to its high recurrenc...
The importance of maximal TURBT in trimodality therapy for muscle-invasive bladder cancer (MIBC) [0.03%]
经尿道膀胱肿瘤电切(TURBT)联合三联疗法治疗肌层浸润性膀胱癌的意义
Chris Ho-Ming Wong,Ivan Ching-Ho Ko,David Ka-Wai Leung et al.
Chris Ho-Ming Wong et al.
Trimodality therapy (TMT), consisting of maximal transurethral resection of bladder tumor (TURBT) followed by concurrent chemoradiotherapy, has emerged as a bladder-sparing alternative to radical cystectomy for select patients with muscle-i...
The role of blue light cystoscopy and additional operative evaluations during first surveillance after induction therapy for high-risk NMIBC [0.03%]
诱导治疗后高危NMIBC首次监测中蓝光膀胱镜和额外手术评估的作用
Ian M McElree,Ryan L Steinberg,Sarah L Mott et al.
Ian M McElree et al.
Background: During surveillance of high-risk non-muscle invasive bladder cancer (HR-NMIBC), occult disease can be missed by standard cystoscopy. Objective...
Intravesical instillation of chemotherapy before surgery for upper tract urothelial cancer [0.03%]
上尿路尿路上皮癌术前化疗灌注治疗
Edward M Messing,Kamil Malshy
Edward M Messing
Higher resilience in radical cystectomy patients is associated with improved health related quality of life post-operatively [0.03%]
较高的弹性能改善膀胱全切术患者的术后相关生活质量
Lauren N Kennedy,Caleb S Miller,Danica N May et al.
Lauren N Kennedy et al.
Background: Radical cystectomy (RC) with urinary diversion (UD) is associated with substantial morbidity. Enhanced recovery after surgery protocols, increased robotic usage, and improvements in urinary diversion have been...
Advancements in systemic therapy for muscle-invasive bladder cancer: A systematic review from the beginning to the latest updates [0.03%]
肌层浸润性膀胱癌系统治疗进展：从最初到最新的更新系统综述
Takafumi Yanagisawa,Akihiro Matsukawa,Jeremy Yuen-Chun Teoh et al.
Takafumi Yanagisawa et al.
Context: Several phase III randomized controlled trials (RCTs) have shown the importance of perioperative systemic therapy, especially for the efficacy of immune checkpoint inhibitors (ICIs) in both neoadjuvant and adjuva...
Hongda Zhao,Vincy Wing Sze Ho,Kang Liu et al.
Hongda Zhao et al.
Background: Bladder cancer (BC), one of the most prevalent and aggressive urological malignancies, poses significant challenges in diagnosis, treatment, and recurrence management. Patient-derived organoid provides new dir...
Piyush K Agarwal,Cora N Sternberg
Piyush K Agarwal